Clinique Saint-Joseph

Liège B 4000

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Breast Neoplasms, HER2 Positive Breast Cancer, Lung Cancer

Studies at this site

• Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer — Completed
• A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer — Completed
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early
• Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission — Completed